Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

May 21, 2020 6:56 PM ET

Smart Inhalers Market is Anticipated to Grow USD 445.40 million By 2027

iCrowd Newswire - May 21, 2020

The Smart Inhalers Market report offers an in-depth analysis of various factors promoting and demoting the growth of the market during the mentioned forecast period. The information provided in the report is gathered from primary and secondary research methods.

The global smart inhalers marketis set to gain impetus from the rising utilization of digital technology in the field of healthcare devices. It is aiding in increasing the efficiency of drug delivery devices and is, in turn, speeding up the treatment procedures. This information is published byFortune Business Insights™in a recent report, titled, “Smart Inhalers Market Size, Share and Industry Analysis, By Product (Dry Powder Inhaler (DPI) – Based Smart Inhalers, Metered Dose Inhaler (MDI) – Based Smart Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Forecast, 2020-2027.” The report further mentions that the smart inhalers market size wasUSD 28.62 millionin 2019 and is projected to reachUSD 445.40 millionby 2027, exhibiting a CAGR of 41.1% during the forecast period.


The report covers:








Request a Sample Copy of the Research Report:


Leading Players operating in the Smart Inhalers Market are:


Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:













The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.


We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


Click here to get the short-term and long-term impact of COVID-19 on this Smart Inhalers Market.


Please visit:


Drivers and Restraints-


Rising Prevalence of Acute Respiratory Ailments to Spur Growth


The Global Burden of Disease conducted a study in 2015. It states that between 1990 to 2015, the cases of chronic obstructive pulmonary disease (COPD) upsurged by approximately 14.7%. It proves that the rising incidence of chronic respiratory diseases, such as COPD and asthma worldwide is likely to propel the smart inhalation devices market growth during the forthcoming period. In addition to that, patients are nowadays inclining gradually towards connected drug delivery devices from the manual ones because of the former’s possession of superior properties. Coupled with this, the increasing focus of the masses on preventive care would contribute to the market growth. However, manual inhalers are still considered to be substitute products. It may obstruct growth.




MDI- Based Smart Inhalers Segment to Lead Backed by Their Clinical Benefits


In terms of product, the market is segregated into metered dose inhaler (MDI)-based and dry powder inhaler (DPI)-based inhalers. Out of these, the MDI-based smart inhalers segment is set to lead by gaining the maximum digital inhalers market share in the coming years. These smart inhalers have several clinical benefits. They aid in assisting in controlling and monitoring the amount of drug to be supplied as per the patient’s requirements. Many industry giants are also conducting research and development activities to come up with innovative technologies to be equipped in the medical devices.


Have Any Query? Ask Our Experts:


Detailed Table of Content:




4.1Recent Industry Developments Such as Mergers and Acquisitions


4.2 Regulatory Scenario for Key Countries


4.3 Technological Advancements Pertaining to Smart Inhalers


4.4 Industry Background Pertaining to Smart Inhalers


4.5 Key Industry Trends


4.6 New Product Launch

5.2.1 Dry Powder Inhaler (DPI)- based Inhalers


5.2.2 Metered Dose Inhaler (MDI)- based Inhalers




5.3.1 Asthma


5.3.2 Chronic Obstructive Pulmonary Disease (COPD)




5.4.1 Hospital Pharmacies


5.4.2 Retail Pharmacies


5.4.3 Online Channel




5.5.1 North America


5.5.2 Europe


5.5.3 Asia Pacific


5.5.4 Rest of the World (RoW)

6.2.1 Dry Powder Inhaler (DPI)- based Inhalers


6.2.2 Metered Dose Inhaler (MDI)- based Inhalers




6.3.1 Asthma


6.3.2 Chronic Obstructive Pulmonary Disease (COPD)




6.4.1 Hospital Pharmacies


6.4.2 Retail Pharmacies


6.4.3 Online Channel




6.5.1 U.S.


6.5.2 Canada

7.2.1 Dry Powder Inhaler (DPI)- based Inhalers


7.2.2 Metered Dose Inhaler (MDI)- based Inhalers




7.3.1 Asthma


7.3.2 Chronic Obstructive Pulmonary Disease (COPD)




7.4.1 Hospital Pharmacies


7.4.2 Retail Pharmacies


7.4.3 Online Channel




7.5.1 U.K.


7.5.2 Germany


7.5.3 France


7.5.4 Spain


7.5.5 Italy


7.5.6 Rest of Europe

8.2.1 Dry Powder Inhaler (DPI)- based Inhalers


8.2.2 Metered Dose Inhaler (MDI)- based Inhalers




8.3.1 Asthma


8.3.2 Chronic Obstructive Pulmonary Disease (COPD)




8.4.1 Hospital Pharmacies


8.4.2 Retail Pharmacies


8.4.3 Online Channel




8.5.1 Japan


8.5.2 China


8.5.3 India


8.5.4 Australia


8.5.5 Rest of Asia Pacific

9.2.1 Dry Powder Inhaler (DPI)- based Inhalers


9.2.2 Metered Dose Inhaler (MDI)- based Inhalers




9.3.1 Asthma


9.3.2 Chronic Obstructive Pulmonary Disease (COPD)




9.4.1 Hospital Pharmacies


9.4.2 Retail Pharmacies


9.4.3 Online Channel

10.5.1 Adherium


10.5.2 Propeller Health


10.5.3 Cohero Health Inc.


10.5.4 GlaxoSmithKline


10.5.5 AstraZeneca plc


10.5.6 Novartis AG


10.5.7 3M Company


10.5.8 Teva Pharmaceuticals


10.5.9 Vectura Group


10.5.10 Others




Report Focus:














Reasons to Purchase this Report:







About Us:


Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.


Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.


At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:


Fortune Business Insights™ Pvt. Ltd.


308, Supreme Headquarters,


Survey No. 36, Baner,


Pune-Bangalore Highway,


Pune – 411045, Maharashtra, India.




US :+1 424 253 0390


UK : +44 2071 939123


APAC : +91 744 740 1245


Email:[email protected]



Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Smart Inhalers Market is Anticipated to Grow USD 445.40 million By 2027


Tags:    Wire, Research Newswire, English